Inventor
MCCLANAHAN TERRILL K
US22 patents
⚠️ This page may combine multiple inventors who share the name “MCCLANAHAN TERRILL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
15 patentsUS7282204B2Oct 16, 2007
Uses of IL-23 agonists and antagonists; related reagents
SCHERING CORP58 citations95
US7740848B2Jun 22, 2010
Method of treatment of skin inflammation
SCHERING CORP15 citations92
US7501247B2Mar 10, 2009
Method of treating skin inflammation
SCHERING CORP31 citations92
US7427402B2Sep 23, 2008
Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19
SCHERING CORP28 citations92
US6479638B1Nov 12, 2002
Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor
SCHERING CORP19 citations91
US6140076AOct 31, 2000
Ig superfamily `dlair` receptors expressed in monocytes
SCHERING CORP21 citations91
US6274312B1Aug 14, 2001
Intracellular regulatory molecules; related reagents
SCHERING CORP32 citations88
US7776540B2Aug 17, 2010
Method of treating skin inflammation
SCHERING CORP7 citations73
US6503730B1Jan 7, 2003
Nucleic acids encoding a cysteine rich protein
SCHERING CORP9 citations71
US5858707AJan 12, 1999
Purified mammalian nucleobase permeases; nucleic acids; antibodies
SCHERING CORP10 citations71
US7999078B2Aug 16, 2011
Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor
SCHERING CORP2 citations61
US6124436ASep 26, 2000
Purified mammalian monocyte antigens and related reagents
SCHERING CORP5 citations57
US8034341B2Oct 11, 2011
Methods of inhibiting tumor growth using blocking antibodies to IL-23R
SCHERING CORP1 citations51
US7560533B2Jul 14, 2009
Binding compounds specific for cysteine-rich soluble protein C23
SCHERING CORP0 citations50
US7482426B2Jan 27, 2009
C23 Polypeptides
SCHERING CORP0 citations50